Hello All
I thought you would be interested to know that the Scottish Medicines Consortium have agreed to make Niraparib available as a maintenance treatment for women with relapsed ovarian cancer who do not have a BRCA mutation.
Their statement is here: scottishmedicines.org.uk/ab...
Best wishes
Anna
Ovacome Support Services Manager